Screener
GNOM vs FINX
Global X Genomics & Biotechnology ETF vs Global X FinTech ETF
Key differences
- GNOM costs 0.18% less per year.
- FINX is significantly larger than GNOM — larger funds tend to be more liquid and less likely to close.
- Over the last 3 years, FINX has delivered higher annualized returns.
Side-by-side comparison
| GNOM | FINX | |
|---|---|---|
| Annual cost (TER) | 0.50% | 0.68% |
| Fund size (AUM) | $51M | $191M |
| Since | 2019 | 2016 |
| Dividend yield | 1.38% | 0.68% |
| Asset class | equity | equity |
| Region | north america | — |
| Strategy | index tracking | index tracking |
| CAGR 1Y | +53.6% | -16.6% |
| CAGR 3Y | -2.6% | +7.0% |
| CAGR 5Y | -10.5% | -8.8% |
| Sharpe 3Y | -0.06 | 0.25 |
| Volatility 1Y | 26.15% | 28.79% |
| Max drawdown | -75.00% | -63.53% |
Green dot indicates the better value for that metric. Performance data is historical and does not predict future results.
Similar to GNOM and FINX
Explore further